Cover Image
市場調查報告書

全球核酸適體市場:成長,趨勢,預測

Global Aptamers Market - Segmented by Type of Products and Applications - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 391436
出版日期 內容資訊 英文 117 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球核酸適體市場:成長,趨勢,預測 Global Aptamers Market - Segmented by Type of Products and Applications - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 117 Pages
簡介

本報告提供全球核酸適體市場相關調查,提供市場趨勢與今後的成長預測,彙整各類型,各用途,各地區趨勢,及打入市場的主要企業簡介等資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要與產業趨勢

  • 核酸適體研究的歷史與發展
  • 目前市場方案
  • 核酸適體市場相關的法律規章的課題
  • 波特五力分析

第6章 促進要素,阻礙要素,機會,課題分析

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 課題

第7章 市場區隔

  • 各類型
    • DNA為基礎的核酸適體
    • RNA為基礎的核酸適體
    • XNA為基礎的核酸適體
    • 胜肽核酸適體
  • 各用途
    • 診斷用試劑
    • 生物感應器
    • 司法鑑定
    • 生化防禦
    • 癌症
    • 治療藥
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他

第8章 競爭環境

  • 新產品上市
  • 合併·收購
  • 協定,聯合,聯盟

第9章 企業簡介

第10章 投資的機會相關分析師預測

第11章 市場未來發展預測

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2572

The global Aptamers market has been estimated to reach USD 401.30 billion in 2023. The market is expected to register a CAGR of 17.89% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.

Advancements in the field of aptamer development technologies

Advancements in aptamer development technologies, increasing R&D, and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Numerous advantages offered by these small molecules in comparison to established antibodies have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth.

Low awareness level and incomplete regulatory policies slow down the market growth

Many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate the clinical investigation during late-stage clinical studies. This factor is likely to affect growth of this market negatively. In addition, other factors such as low awareness about these technologies in middle- & low-income countries and inadequate regulatory structure may hamper the overall growth.

North America to Dominate the Market

The Aptamers market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the Aptamers market due to the increasing technological advancements and high investment & funding to support development of Aptamers. Asia-Pacific is also expected to propel the Aptamers market owing to factors, such as increasing research and development activities and economic growth.

Key developments in the market

In November, 2017, Base Pair Biotechnologies has closed a $3.2 million Series A-3 financing round. Base Pair provides custom aptamer discovery and development services, as well as a line of catalog aptamers. The company said it would use the financing to acquire new lab instruments and other technology in order to to expand its cellular and molecular analysis capabilities, as well as to expand its team.

In December, 2017, Caris Life Sciences Identifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma

Major key players: SOMALOGIC, INC, APTAMER GROUP, APTAMER SCIENCES, INC., BASE PAIR BIOTECHNOLOGIES, INC., NOXXON PHARMA, VIVONICS INC., APTAGEN, LLC etc.

Reasons to purchase this report

Market analysis for the Global Aptamers Market, with region-specific assessments and competition analysis on a global and regional scale.

Analyzing various perspectives of the company with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet in excel.

Customization of the report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. INTRODUCTION

  • 1.1 MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW

  • 5.1 CURRENT MARKET SCENARIO
  • 5.2 PORTER'S FIVE FORCES
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF CONSUMERS
    • 5.2.3 THREATS OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
    • 5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • 6.1 MARKET DRIVERS
    • 6.1.1 HIGH ADVANTAGE OF APTAMERS COMPARED TO ANTIBODIES
    • 6.1.2 ADVANCEMENTS IN THE FIELD OF APTAMER DEVELOPMENT TECHNOLOGIES
    • 6.1.3 GROWING INTEREST OF MANY COMPANIES TO INVEST IN APTAMERS MARKET
    • 6.1.4 PROMISING PIPELINE THERAPEUTICS
  • 6.2 MARKET RESTRAINTS
    • 6.2.1 RISING NUMBER OF SETBACKS OF APTAMER THERAPEUTICS IN LATE STAGE CLINICAL STUDIES
    • 6.2.2 LOW AWARENESS LEVEL AND INCOMPLETE REGULATORY POLICIES SLOW DOWN THE MARKET GROWTH
  • 6.3 OPPORTUNITIES
  • 6.4 KEY CHALLENGES

7. GLOBAL APTAMERS MARKET SEGMENTATION

  • 7.1 BY TYPE
    • 7.1.1 NUCLEIC ACID
    • 7.1.2 PEPTIDE
  • 7.2 BY APPLICATION
    • 7.2.1 DIAGNOSTICS
    • 7.2.2 THERAPEUTICS
    • 7.2.3 RESEARCH AND DEVELOPMENT
    • 7.2.4 OTHERS
  • 7.3 BY GEOGRAPHY
    • 7.3.1 NORTH AMERICA
      • 7.3.1.1 US
      • 7.3.1.2 CANADA
      • 7.3.1.3 MEXICO
    • 7.3.2 EUROPE
      • 7.3.2.1 FRANCE
      • 7.3.2.2 UK
      • 7.3.2.3 GERMANY
      • 7.3.2.4 ITALY
      • 7.3.2.5 SPAIN
      • 7.3.2.6 REST OF EUROPE
    • 7.3.3 ASIA-PACIFIC
      • 7.3.3.1 INDIA
      • 7.3.3.2 CHINA
      • 7.3.3.3 JAPAN
      • 7.3.3.4 AUSTRALIA
      • 7.3.3.5 SOUTH KOREA
      • 7.3.3.6 REST OF APAC
    • 7.3.4 MIDDLE EAST AND AFRICA
      • 7.3.4.1 GCC
      • 7.3.4.2 SOUTH AFRICA
      • 7.3.4.3 REST OF MIDDLE EAST AND AFRICA
    • 7.3.5 SOUTH AMERICA
      • 7.3.5.1 BRAZIL
      • 7.3.5.2 ARGENTINA
      • 7.3.5.3 REST OF SOUTH AMERICA

8. COMPETITIVE LANDSCAPE

  • 8.1 MERGERS AND ACQUISITIONS
  • 8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
  • 8.3 NEW PRODUCT LAUNCHES

9. KEY PLAYERS

  • 9.1 SOMALOGIC, INC.
  • 9.2 APTAMER GROUP
  • 9.3 APTAMER SCIENCES, INC.
  • 9.4 BASE PAIR BIOTECHNOLOGIES, INC.
  • 9.5 NOXXON PHARMA
  • 9.6 VIVONICS INC.
  • 9.7 APTAGEN, LLC
  • 9.8 OTHERS

10. FUTURE OUTLOOK OF THE MARKET

Back to Top